|
Volumn 362, Issue 6, 2000, Pages 526-537
|
CGP 3466 protects dopaminergic neurons in lesion models of Parkinson's disease
a a a |
Author keywords
6 OHDA; CGP 3466; CGP 3466B; Motor perfomance; MPP+; MPTP; Neurodegeneration; Parkinson's disease
|
Indexed keywords
DIBENZO[B,F]OXEPIN 10 YLMETHYL METHYL PROP 2 YNYL AMINE;
DIBENZOXAZEPINE DERIVATIVE;
N METHYL N PROPARGYL 10 AMINOMETHYL DIBENZO[B,F]OXEPIN;
UNCLASSIFIED DRUG;
ANIMAL TISSUE;
APOPTOSIS;
ARTICLE;
CELL DEATH;
DOPAMINERGIC NERVE CELL;
DOSE RESPONSE;
EMBRYO DEVELOPMENT;
ENZYME ACTIVITY;
MOTOR PERFORMANCE;
NERVE DEGENERATION;
NEUROPROTECTION;
NONHUMAN;
PARKINSON DISEASE;
RAT;
SUBSTANTIA NIGRA;
1-METHYL-4-PHENYLPYRIDINIUM;
ANIMALS;
ANTIPARKINSON AGENTS;
BRAIN;
CELL CULTURE TECHNIQUES;
CELL DEATH;
DISEASE MODELS, ANIMAL;
DOPAMINE;
FEMALE;
LIVER;
MESENCEPHALON;
MICE;
MICE, INBRED C57BL;
MONOAMINE OXIDASE;
MONOAMINE OXIDASE INHIBITORS;
NEURONS;
OXEPINS;
OXIDOPAMINE;
PARKINSONIAN DISORDERS;
PREGNANCY;
RATS;
SELEGILINE;
SUBSTANTIA NIGRA;
TRITIUM;
TYROSINE 3-MONOOXYGENASE;
|
EID: 0033659663
PISSN: 00281298
EISSN: None
Source Type: Journal
DOI: 10.1007/s002100000300 Document Type: Article |
Times cited : (47)
|
References (49)
|